Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment ? Single-Center Experience

Özlem ERCELEP; Tugba AKIN TELLİ; Özkan ALAN; Rahib HASANOV; Eda TANRIKULU ŞİMŞEK; Nalan AKGÜL BABACAN; Serap KAYA; Handan KAYA; Faysal DANE; Perran Fulden YUMUK

doi:10.5505/tjo.2020.2207

Current Issue

Forthcoming Issue

Archive

Supplements

Türkçe

The Official Journal of Turkish Society for Radiation Oncology

TURKISH JOURNAL OF ONCOLOGY 2020 , Vol 35 , Num 3

Abstract Full Text PDF Similar Articles Mail to Author

Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment ? Single-Center Experience

Özlem ERCELEP¹,Tugba AKIN TELLİ²,Özkan ALAN²,Rahib HASANOV²,Eda TANRIKULU ŞİMŞEK²,Nalan AKGÜL BABACAN¹,Serap KAYA¹,Handan KAYA³,Faysal DANE²,Perran Fulden YUMUK²

¹Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul-Turkey
²Department of Medical Oncology, Marmara University, Faculty of Medicine, Istanbul-Turkey
³Department of Pathology, Marmara University, Faculty of Medicine, Istanbul-Turkey DOI : 10.5505/tjo.2020.2207 Keywords :

Home

Informations For Authors

Retractions

Contact